MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Feasibility of implementing a long-term mobile device program in PD patients

L.R. Bataille, L.D. Herron, M. Afek, I. Feldman, C. Admati, S. Chowdhury (New York, NY, USA)

Meeting: 2016 International Congress

Abstract Number: 2017

Keywords: Tremors: Clinical features

Session Information

Date: Thursday, June 23, 2016

Session Title: Parkinson's disease: Clinical trials, pharmacology and treatment

Session Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To evaluate the feasibility of Parkinson’s patients utilizing the Fox Insight Wear smartphone application in an environment outside the clinic.

Background: A reliable quantitative tool based on consumer electronics utilizing wearable sensors for evaluating motor function in PD patients could be valuable both for routine care, informing the natural progression of PD and serving as an objective outcome measure for trials of novel therapies. The Michael J. Fox Foundation and Intel developed a smartphone app that collects 50Hz accelerometer data per second about users’ movements when paired with a smartwatch. Algorithms are applied to this objective data and insights about patient’s motor symptoms (e.g. activity level, tremor, effect of medication on walking and hand rotation) are displayed on the app in real-time.

Methods: We conducted a virtual study to determine whether it is feasible to implement a large scale wearable device program in PD patients. Parkinson’s patients with approved smartphone devices consented to the study online and received a Pebble Smartwatch and study instructions via post. Subjects were encouraged to wear the watch 24/7 and considered compliant if they streamed data at least five hours/day for 30 days. A call center was available for users who encountered technical difficulties.

Results: 417 PD patients completed the study. The mean age of subjects was 59 (SD 11.65), mean age of onset was 53.2 (SD 11.78), and mean years since diagnosis was 5.57 (SD 4.58). 76% (318/417) of subjects were compliant users and mean number of hours streamed was 1566. 8% (33/417) of users streamed < five hours/day for 20-30 days and 17% streamed < 10 days. In total, 523,745 watch hours were collected. The call center received 736 emails and 875 support phone call inquiries. The top three reasons for support inquiries included technology feature malfunction (70%), activation (17%) and login issues (8%).

Conclusions: Long-term, continuous use of a smartphone application among Parkinson’s patients is feasible. Offering smartphone application features that help users manage their symptoms and offering live support to troubleshoot technical issues contributed to high retention rates.

To cite this abstract in AMA style:

L.R. Bataille, L.D. Herron, M. Afek, I. Feldman, C. Admati, S. Chowdhury. Feasibility of implementing a long-term mobile device program in PD patients [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/feasibility-of-implementing-a-long-term-mobile-device-program-in-pd-patients/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/feasibility-of-implementing-a-long-term-mobile-device-program-in-pd-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley